Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: ASTELLAS GENE THERAPIES, INC. A DELAWARE CORPORATION
Client-Reported Lobbying Expenses
$860K
14 filings
Summary
ASTELLAS GENE THERAPIES, INC. A DELAWARE CORPORATION is an organization, based in CA. Its political footprint includes $860K in client-reported lobbying expenses. Lobbying activity focuses on Health Issues, Medicare/Medicaid. Political activity spans from 2020 to 2024.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↓ 100% YoY
2024: — (complete years)
Activity data: Senate LDA